- Entry
- $4.74
- Final
- $3.48 -26.6%
- Target
- —
- Score
- -1.00
[https://www.tradingview.com/news/urn:summary\_document\_transcript:quartr.com:2599568:0-sana-gene-edited-cell-therapy-for-type-1-diabetes-shows-durable-immune-evasion-phase-i-trials-planned/](https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2599568:0-sana-gene-edited-cell-therapy-for-type-1-diabetes-shows-durable-immune-evasion-phase-i-trials-planned/)
— ORIGINAL POST ·
SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
· r/wallstreetbets
· Jan 15, 2026